CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 175 of 242 entries

View as:

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01565018 Org: User:

Start: 03/31/12 End: 07/31/12 Due: 07/31/13

Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures

Phase: N/A Priority: Normal

NCT ID: NCT01921205 Org: User:

Start: 08/29/13 End: 01/24/17 Due: 01/24/18

CUTE (Chronic Urticaria Treatment Evaluation)

Phase: N/A Priority: Normal

NCT ID: NCT00264303 Org: User:

Start: 12/31/05 End: 01/31/07 Due: 01/31/08

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Phase: N/A Priority: Normal

NCT ID: NCT00524836 Org: User:

Start: 09/30/03 End: 02/29/04 Due: 02/28/05

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

Phase: N/A Priority: Normal

NCT ID: NCT00354367 Org: User:

Start: 01/31/07 End: - Due: -

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00643500 Org: User:

Start: 01/31/02 End: 05/31/03 Due: 05/31/04

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT00329303 Org: User:

Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00515619 Org: User:

Start: 12/31/04 End: 08/31/10 Due: 08/31/11

Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00333788 Org: User:

Start: 10/31/06 End: 04/30/10 Due: 04/30/11

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months

Phase: N/A Priority: Normal

NCT ID: NCT00628108 Org: User:

Start: 03/31/08 End: 09/30/08 Due: 09/30/09

An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam

Phase: N/A Priority: Normal

NCT ID: NCT00761774 Org: User:

Start: 11/30/08 End: 03/31/17 Due: 03/31/18

Transdermal Rotigotine User Surveillance Study

Phase: N/A Priority: Normal

NCT ID: NCT00599339 Org: User:

Start: 06/30/06 End: 04/30/14 Due: 04/30/15

Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01091220 Org: User:

Start: 03/31/10 End: 03/31/11 Due: 03/31/12

Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00356408 Org: User:

Start: 01/31/07 End: 02/28/10 Due: 02/28/11

A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00160602 Org: User:

Start: 06/30/05 End: 09/30/06 Due: 09/30/07

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal

NCT ID: NCT00498186 Org: User:

Start: 07/31/03 End: 04/30/09 Due: 04/30/10

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00610454 Org: User:

Start: 06/30/04 End: 08/31/04 Due: 08/31/05

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

Phase: N/A Priority: Normal

NCT ID: NCT00291642 Org: User:

Start: 01/01/06 End: 04/01/06 Due: 04/01/07

Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal

NCT ID: NCT00113971 Org: User:

Start: 04/30/05 End: 06/30/07 Due: 06/30/08

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

Phase: N/A Priority: Normal

NCT ID: NCT00521040 Org: User:

Start: 02/29/04 End: 07/31/04 Due: 07/31/05

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01675024 Org: User:

Start: 08/31/12 End: 09/30/12 Due: 09/30/13

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms

Phase: N/A Priority: Normal

NCT ID: NCT00296192 Org: User:

Start: 02/28/06 End: 06/30/06 Due: 06/30/07

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Phase: N/A Priority: Normal

NCT ID: NCT00993668 Org: User:

Start: 09/30/09 End: 02/28/11 Due: 02/28/12

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Phase: N/A Priority: Normal

NCT ID: NCT00525382 Org: User:

Start: 08/31/03 End: 03/31/04 Due: 03/31/05

Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

Phase: N/A Priority: Normal

NCT ID: NCT01059903 Org: User:

Start: 01/31/10 End: 03/31/10 Due: 03/31/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects	NCT01565018	UCB Pharma	user2@example.com	None	2012-03-31	2012-07-31	2013-07-31	-	-	2025-07-14
Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures	NCT01921205	UCB Pharma	user2@example.com	None	2013-08-29	2017-01-24	2018-01-24	-	-	2025-07-14
CUTE (Chronic Urticaria Treatment Evaluation)	NCT00264303	UCB Pharma	user2@example.com	None	2005-12-31	2007-01-31	2008-01-31	-	-	2025-07-14
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis	NCT00524836	UCB Pharma	user2@example.com	None	2003-09-30	2004-02-29	2005-02-28	-	-	2025-07-14
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas	NCT00354367	UCB Pharma	user2@example.com	None	2007-01-31	-	-	-	-	2025-07-14
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy	NCT00643500	UCB Pharma	user2@example.com	None	2002-01-31	2003-05-31	2004-05-31	-	-	2025-07-14
Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis	NCT00329303	UCB Pharma	user2@example.com	None	2006-04-30	2007-05-31	2008-05-31	-	-	2025-07-14
Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures	NCT00515619	UCB Pharma	user2@example.com	None	2004-12-31	2010-08-31	2011-08-31	-	-	2025-07-14
Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease	NCT00333788	UCB Pharma	user2@example.com	None	2006-10-31	2010-04-30	2011-04-30	-	-	2025-07-14
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months	NCT00628108	UCB Pharma	user2@example.com	None	2008-03-31	2008-09-30	2009-09-30	-	-	2025-07-14
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam	NCT00761774	UCB Pharma	user2@example.com	None	2008-11-30	2017-03-31	2018-03-31	-	-	2025-07-14
Transdermal Rotigotine User Surveillance Study	NCT00599339	UCB Pharma	user2@example.com	None	2006-06-30	2014-04-30	2015-04-30	-	-	2025-07-14
Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers	NCT01091220	UCB Pharma	user2@example.com	None	2010-03-31	2011-03-31	2012-03-31	-	-	2025-07-14
Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease	NCT00356408	UCB Pharma	user2@example.com	None	2007-01-31	2010-02-28	2011-02-28	-	-	2025-07-14
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis	NCT00160602	UCB Pharma	user2@example.com	None	2005-06-30	2006-09-30	2007-09-30	-	-	2025-07-14
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)	NCT00498186	UCB Pharma	user2@example.com	None	2003-07-31	2009-04-30	2010-04-30	-	-	2025-07-14
Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures	NCT00610454	UCB Pharma	user2@example.com	None	2004-06-30	2004-08-31	2005-08-31	-	-	2025-07-14
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen	NCT00291642	UCB Pharma	user2@example.com	None	2006-01-01	2006-04-01	2007-04-01	-	-	2025-07-14
Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)	NCT00113971	UCB Pharma	user2@example.com	None	2005-04-30	2007-06-30	2008-06-30	-	-	2025-07-14
Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR	NCT00521040	UCB Pharma	user2@example.com	None	2004-02-29	2004-07-31	2005-07-31	-	-	2025-07-14
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects	NCT01675024	UCB Pharma	user2@example.com	None	2012-08-31	2012-09-30	2013-09-30	-	-	2025-07-14
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms	NCT00296192	UCB Pharma	user2@example.com	None	2006-02-28	2006-06-30	2007-06-30	-	-	2025-07-14
Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines	NCT00993668	UCB Pharma	user2@example.com	None	2009-09-30	2011-02-28	2012-02-28	-	-	2025-07-14
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria	NCT00525382	UCB Pharma	user2@example.com	None	2003-08-31	2004-03-31	2005-03-31	-	-	2025-07-14
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body	NCT01059903	UCB Pharma	user2@example.com	None	2010-01-31	2010-03-31	2011-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance